Efficacy of Adderall® for Attention-Deficit/Hyperactivity Disorder: A meta-analysis
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Stimulant medication has, for many years, been the pharmacological treatment of choice for children and adults with Attention- Deficit/Hyperactivity Disorder (ADHD). Several studies have shown Adderall®, to be efficacious for measures of inattention, hyperactivity-impulsivity, aggression, disruptive behavior, and academic productivity. Although these studies provide useful information for clinicians treating ADHD children and adults, the variability in efficacy among the different types of measures used within each study has not been comprehensively examined. Thus, to provide a clearer picture of what conclusions can be drawn from these studies, we performed a meta-analysis. Data from the six available studies of standard release Adderall® show it to be efficacious for symptoms of inattention, hyperactivity- impulsivity, and aggression, as well as global ratings. Its efficacy was significant for clinician, parent, and teacher ratings, and for both fixed- and best-dose designs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, T., Biederman, J., Wilens, T., Faraone, S., Prince, J., Gerard, K., Doyle, R., Parekh, A., Kagan, J., & Bearman, S. K. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.775 · Cited by 250
Self-citationPelham, W. E., Gnagy, E. M., Chronis, A. M., Burrows-MacLean, L., Fabiano, G. A., Onyango, A. N., Meichenbaum, D. L., Williams, A., Aronoff, H. R., & Steiner, R. L. (1999) · PEDIATRICS · doi:10.1542/peds.104.6.1300 · Cited by 138
Double-Blind, Placebo-Controlled Study of Single-Dose Amphetamine Formulations in ADHD
JAMES, R. S., SHARP, W. S., BASTAIN, T. M., LEE, P. P., WALTER, J. M., CZARNOLEWSKI, M., & CASTELLANOS, F. X. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200111000-00006 · Cited by 92
Faraone, S. V., Biederman, J., & Roe, C. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200210000-00005 · Cited by 91
Self-citation
Cited by
Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
Faraone, S. V., & Buitelaar, J. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0054-3 · Cited by 485
Self-citationLeucht, S., Hierl, S., Kissling, W., Dold, M., & Davis, J. M. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.096594 · Cited by 451
Faraone, S. V., & Glatt, S. J. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04902pur · Cited by 387
Self-citationPsychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation
Wood, S., Sage, J. R., Shuman, T., & Anagnostaras, S. G. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007054 · Cited by 259
Comparing the efficacy of medications for ADHD using meta-analysis.
(2006) · PubMed Central · Cited by 230
Metadata
- Authors
- Faraone, S. V., & Biederman, J.
- Venue
- Journal of Attention Disorders
- Publisher
- SAGE Publications
- Published
- 2002-09
- Volume
- 6
- Issue
- 2
- Pages
- 69-75
- ISSN
- 1087-0547 (ISSN-L)
- 1557-1246
- OpenAlex
- W1929285963
- Cited by
- 52
- References
- 4
- FWCI
- 0.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of Adderall® for Attention-Deficit/Hyperactivity Disorder: A meta-analysis. https://app.cochat.ai/papers/10.1177/108705470200600203
- The paper
- Faraone, S. V., & Biederman, J. (2002). Efficacy of Adderall® for Attention-Deficit/Hyperactivity Disorder: A meta-analysis. Journal of Attention Disorders. https://doi.org/10.1177/108705470200600203
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.